Tevogen Bio Holdings Inc — Quarterly Cash Flow (NASDAQ:TVGN) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 4.29 M3.46 M4.07 M4.27 M4.49 M Total liabilities 10.48 M10.14 M11.79 M13.75 M12.32 M Total equity -6.19 M-6.67 M-7.72 M-9.48 M-7.82 M Total liabilities & shareholders' equities 4.29 M3.46 M4.07 M4.27 M4.49 M Total debt ————— Net debt —————

Nouvelles

Tevogen-Aufsichtsrat erwägt einmalige Sonderausschüttung

Tevogen board to evaluate potential special cash dividend

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

Tevogen Bio Holdings verstößt gegen NASDAQ-Mindestkursanforderung

Tevogen Bio Holdings receives Nasdaq notice for minimum bid price deficiency

Tevogen announces $9-11 billion valuation for COVID-19 T cell therapy

Tevogen shares EBV treatment forecast with $3.5 billion revenue potential

Tevogen highlights need for SARS-CoV-2 treatments for immunocompromised

Tevogen reports 60% rise in institutional ownership in Q1 2025

Tevogen Bio stock rises amid $1 million grant funding

Tevogen executives and directors own over 74% of company stock

Tevogen Bio Holdings grants CEO 8 million restricted shares, updates outstanding stock